0001513363 2024-02-29 2024-02-29 0001513363 2024-02-28 2024-02-28 iso4217:USD false 0001513363 8-K 2024-02-29 Fidus Investment Corporation MD 814-00861 27-5017321 1603 Orrington Avenue Suite 1005 Evanston IL 60201 847 859-3940 false false false false Common Stock, par value $0.001 per share FDUS NASDAQ false <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 10, 2022, Fidus Investment Corporation (the “Company”) established an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“at-the-market”</div></div> offering (the “ATM Program”) through which the Company may sell, from time to time through the Sales Agents (as defined below), shares of the Company’s common stock, par value $0.001 per share (the “Shares”). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 29, 2024, the Company increased the maximum amount of Shares to be sold through the ATM Program to $300.0 million from $150.0 million. In connection with the upsize of the ATM Program, the Company entered into amendment no. 2 (“Amendment No. 2”) to the equity distribution agreement, dated November 10, 2022 (the “Equity Distribution Agreement”) with Fidus Investment Advisors, LLC, Raymond James &amp; Associates, Inc. (“Raymond James”) and B. Riley Securities, Inc. (“B. Riley” and together with Raymond James, the “Sales Agents”). Under the Equity Distribution Agreement, as amended by Amendment No. 2, the Company may, but has no obligation to, issue and sell up to $300.0 million in aggregate amount of Shares in the ATM Program, from time to time through the Sales Agents, or to them, as principal for their own account. As of February 28, 2024 and after giving effect to Amendment No. 2, up to approximately $178.1 million in aggregate amount of the Shares will remain available for sale under the ATM Program. </div> ATM Program 178100000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further details regarding the Equity Distribution Agreement, as amended by Amendment No. 2, and the ATM Program are set forth in the Company’s prospectus supplement, dated November 10, 2022 (the “ATM Prospectus Supplement”), supplement no. 1 to the ATM Prospectus Supplement, dated March 2, 2023 (“Supplement No. 1”), supplement no. 2 to the ATM Prospectus Supplement, dated May 8, 2023 (“Supplement No. 2”), supplement no. 3 to the ATM Prospectus Supplement, dated August 4, 2023 (“Supplement No. 3”), supplement no. 4 to the ATM Prospectus Supplement, dated August 11, 2023 (“Supplement No. 4”), supplement no. 5 to the ATM Prospectus Supplement, dated November 2, 2023 (“Supplement No. 5”), and supplement no. 6 to the ATM Prospectus Supplement, dated February 29, 2024 (“Supplement No. 6” and together with the ATM Prospectus Supplement, Supplement No. 1, Supplement No. 2, Supplement No. 3, Supplement No. 4, and Supplement No. 5 and including, in each case, any information incorporated by reference therein, the “Prospectus”), filed by the Company with the Securities and Exchange Commission. </div>